Factors Affecting Rates of Visual Field Progression in Glaucoma Patients with Optic Disc Hemorrhage

Ophthalmology

Volumn 117, Issue 1, 2010, Pages 24-29

  Prata, Tiago S ^a   De Moraes, Carlos Gustavo V ^a   Teng, Christopher C ^a   Tello, Celso ^a,b   Ritch, Robert ^a,b   Liebmann, Jeffrey M ^c,d  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EAR AND THROAT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXFOLIATION SYNDROME; FEMALE; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; HYPOTENSION; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OPTIC DISK; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RECURRENT DISEASE; RISK FACTOR; VISUAL FIELD;

AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; OPTIC DISK; OPTIC NERVE DISEASES; PERIMETRY; PHOTOGRAPHY; RETINAL HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; VISION DISORDERS; VISUAL FIELDS;

EID: 72749087927     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.06.028     Document Type: Article

References (47)

1. Weinreb R.N., and Khaw P.T. Primary open-angle glaucoma. Lancet 363 (2004) 1711-1720
2. Kass M.A., Heuer D.K., Higginbotham E.J., et al., Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
3. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126 (1998) 487-497
4. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126 (1998) 498-505
5. Burgoyne C.F., Downs J.C., Bellezza A.J., et al. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 24 (2005) 39-73
6. Bengtsson B., and Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol 145 (2008) 343-353
7. Heijl A., Bengtsson B., Chauhan B.C., et al. A comparison of visual field progression criteria of 3 major glaucoma trials in Early Manifest Glaucoma Trial patients. Ophthalmology 115 (2008) 1557-1565
8. Gordon M.O., Beiser J.A., Brandt J.D., et al., Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720
9. Leske M.C., Heijl A., Hyman L., et al., EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology 114 (2007) 1965-1972
10. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 (2004) 1627-1635
11. Nakagami T., Yamazaki Y., and Hayamizu F. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 50 (2006) 38-43
12. Miglior S., Torri V., Zeyen T., et al., European Glaucoma Prevention Study (EGPS) Group. Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol 144 (2007) 266-275
13. Musch D.C., Gillespie B.W., Lichter P.R., et al., CIGTS Study Investigators. Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors. Ophthalmology 116 (2009) 200-207
14. Drance S., Anderson D.R., Schulzer M., and Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131 (2001) 699-708
15. Bjerrum J. Om en Tilfojelse til den Saedvanlige Synsfelfundersogelse samt om Synfeltet ved Glaukom. Nord Ophthalmol Tidsskr 2 (1889) 141-185
16. Bjerrum J. Om Glaukomets Kliniske Afgraensning. Nord Ophthalmol Tidsskr 5 (1892) 129-138
17. Drance S.M., Fairclough M., Butler D.M., and Kottler M.S. The importance of disc hemorrhage in the prognosis of chronic open angle glaucoma. Arch Ophthalmol 95 (1977) 226-228
18. Jonas J.B., and Xu L. Optic disc hemorrhages in glaucoma. Am J Ophthalmol 118 (1994) 1-8
19. Healey P.R., Mitchell P., Smith W., and Wang J.J. Optic disc hemorrhages in a population with and without signs of glaucoma. Ophthalmology 105 (1998) 216-223
20. Siegner S.W., and Netland P.A. Optic disc hemorrhages and progression of glaucoma. Ophthalmology 103 (1996) 1014-1024
21. Ishida K., Yamamoto T., Sugiyama K., and Kitazawa Y. Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol 129 (2000) 707-714
22. Gordon J., and Piltz-Seymour J.R. The significance of optic disc hemorrhages in glaucoma. J Glaucoma 6 (1997) 62-64
23. Budenz D.L., Anderson D.R., Feuer W.J., et al., Ocular Hypertension Treatment Study Group. Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology 113 (2006) 2137-2143
24. Leske M.C., Heijl A., Hussein M., et al., Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 121 (2003) 48-56
25. Susanna R., Drance S.M., and Douglas G.R. Disc hemorrhages in patients with elevated intraocular pressure: occurrence with and without field changes. Arch Ophthalmol 97 (1979) 284-285
26. Airaksinen P.J., Mustonen E., and Alanko H.I. Optic disc hemorrhages: analysis of stereophotographs and clinical data of 112 patients. Arch Ophthalmol 99 (1981) 1795-1801
27. Viswanathan A.C., Fitzke F.W., and Hitchings R.A. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol 81 (1997) 1037-1042
28. Chauhan B.C., Garway-Heath D.F., Goñi F.J., et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 92 (2008) 569-573
29. Crabb D.P., Fitzke F.W., McNaught A.I., et al. Improving the prediction of visual field progression in glaucoma using spatial processing. Ophthalmology 104 (1997) 517-524
30. Jeoung J.W., Park K.H., Kim J.M., et al. Optic disc hemorrhage may be associated with retinal nerve fiber loss in otherwise normal eyes. Ophthalmology 115 (2008) 2132-2140
31. Rasker M.T., van den Enden A., Bakker D., and Hoyng P.F. Deterioration of visual fields in patients with glaucoma with and without optic disc hemorrhages. Arch Ophthalmol 115 (1997) 1257-1262
32. Martus P., Stroux A., Budde W.M., et al. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma. Am J Ophthalmol 139 (2005) 999-1009
33. O'Brien C., Schwartz B., Takamoto T., and Wu D.C. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol 111 (1991) 491-500
34. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 134 (2002) 499-512
35. Lan Y.W., Wang I.J., Hsiao Y.C., et al. Characteristics of disc hemorrhage in primary angle-closure glaucoma. Ophthalmology 115 (2008) 1328-1333
36. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
37. Miyake T., Sawada A., Yamamoto T., et al. Incidence of disc hemorrhages in open-angle glaucoma before and after trabeculectomy. J Glaucoma 15 (2006) 164-171
38. Bengtsson B., Leske M.C., Yang Z., Heijl A., and EMGT Group. Disc hemorrhages and treatment in the Early Manifest Glaucoma Trial. Ophthalmology 115 (2008) 2044-2048
39. Anderson D.R., Drance S.M., Schulzer M., and Collaborative Normal-Tension Glaucoma Study Group. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol 136 (2003) 820-829
40. Jonas J.B., Stroux A., Oberacher-Velten I.M., et al. Central corneal thickness and development of glaucomatous optic disk hemorrhages. Am J Ophthalmol 140 (2005) 1139-1141
41. Medeiros F.A., Sample P.A., Zangwill L.M., et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 136 (2003) 805-813
42. Sveinsson K. The frequency of senile exfoliation in Iceland: fibrillopathy or pseudoexfoliation. Acta Ophthalmol (Copenh) 52 (1974) 596-602
43. Layden W.E., and Shaffer R.N. Exfoliation syndrome. Am J Ophthalmol 78 (1974) 835-841
44. Stewart W.C., Kolker A.E., Sharpe E.D., et al. Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma. Eur J Ophthalmol 18 (2008) 765-770
45. European Glaucoma Prevention Study (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114 (2007) 3-9
46. Kim S.H., and Park K.H. The relationship between recurrent optic disc hemorrhage and glaucoma progression. Ophthalmology 113 (2006) 598-602
47. de Moraes C.G., Prata T.S., Liebmann C.A., et al. Spatially consistent, localized visual field loss precedes and follows disc hemorrhage. Invest Ophthalmol Vis Sci 50 (2009) 4727-4733